The history of Viagra presents a intricate picture for those considering investment. While the initial launch generated massive returns, the expiration of its exclusive rights opened the avenue to off-brand competitors, dramatically diminishing revenue. This poses a particular dilemma for drug manufacturers depending on comparable blockbuster medic

The history of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in income, its exclusivity period created a wave of knock-off medications, significantly eroding its position . While specific firms may seek to capitalize on related treatments , the current landscape